论文部分内容阅读
目的:对晚期肝癌并发肝硬化患者采用复方甘草酸苷注射液联合斑蝥酸钠维生素B6注射液进行治疗,对其疗效进行观察和分析。方法:对我院收治的168例晚期肝癌并发肝硬化患者进行随机分组,分成试验组和对照组,分别为84例。对照组:对患者使用斑蝥酸钠维生素B6进行治疗。试验组:在对照组的基础上,对患者加用复方甘草酸苷注射液进行治疗。对2组患者都进行抗肿瘤、保肝和对症治疗。结果:试验组患者的生化指标改善和转阴率要明显优于对照组,差异显著,具有统计学意义(P<0.05)。2组患者没有出现明显性的不良反应。结论:对晚期肝癌并发肝硬化患者采用复方甘草酸苷注射液联合斑蝥酸钠维生素B6注射液进行治疗,效果显著,并且不良反应少,值得在临床上进行推广和应用。
Objective: To treat patients with advanced hepatocellular carcinoma complicated by liver cirrhosis by compound glycyrrhizin injection combined with cantharidin sodium and vitamin B6 injection. The curative effect was observed and analyzed. Methods: 168 patients with advanced hepatocellular carcinoma complicated with liver cirrhosis were randomly divided into experimental group and control group, which were 84 cases. Control group: Patients were treated with cantharidin and vitamin B6. Test group: On the basis of the control group, patients were treated with compound glycyrrhizin injection. Anti-tumor, liver protection and symptomatic treatment were performed on both groups of patients. Results: The improvement of biochemical indexes and negative rate of the experimental group were significantly better than those of the control group. The difference was statistically significant (P<0.05). There were no obvious adverse reactions in the 2 groups. Conclusion: The use of compound glycyrrhizin injection combined with cantharidin sodium vitamin B6 injection in patients with advanced hepatocellular carcinoma complicated with cirrhosis has obvious effect and less adverse reactions. It is worthy of promotion and application in clinical practice.